Home/Filings/4/0001779453-21-000004
4//SEC Filing

EPIQ Capital Group, LLC 4

Accession 0001779453-21-000004

CIK 0001652724other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 6:39 PM ET

Size

30.5 KB

Accession

0001779453-21-000004

Insider Transaction Report

Form 4
Period: 2021-02-05
Transactions
  • Conversion

    Common Stock

    2021-02-05+32,17632,176 total
  • Purchase

    Common Stock

    2021-02-05$17.00/sh+3,461,764$58,849,9883,461,764 total
  • Conversion

    Common Stock

    2021-02-05+5,173,0265,173,026 total
  • Conversion

    Series B Convertible Preferred

    2021-02-053,754,0840 total
    Common Stock (3,754,084 underlying)
  • Conversion

    Common Stock

    2021-02-05+3,754,0843,754,084 total
  • Conversion

    Series C Convertible Preferred

    2021-02-055,173,0260 total
    Common Stock (5,173,026 underlying)
  • Conversion

    2020B Convertible Promissory Note

    2021-02-05$17.00/sh735,475$12,503,0750 total
    Exp: 2022-12-11Common Stock (735,475 underlying)
  • Conversion

    Common Stock

    2021-02-05$17.00/sh+735,475$12,503,075735,475 total
  • Conversion

    Series B Convertible Preferred

    2021-02-0532,1760 total
    Common Stock (32,176 underlying)
Transactions
  • Conversion

    Common Stock

    2021-02-05+3,754,0843,754,084 total
  • Purchase

    Common Stock

    2021-02-05$17.00/sh+3,461,764$58,849,9883,461,764 total
  • Conversion

    Series C Convertible Preferred

    2021-02-055,173,0260 total
    Common Stock (5,173,026 underlying)
  • Conversion

    Common Stock

    2021-02-05+5,173,0265,173,026 total
  • Conversion

    Common Stock

    2021-02-05$17.00/sh+735,475$12,503,075735,475 total
  • Conversion

    Series B Convertible Preferred

    2021-02-053,754,0840 total
    Common Stock (3,754,084 underlying)
  • Conversion

    Common Stock

    2021-02-05+32,17632,176 total
  • Conversion

    Series B Convertible Preferred

    2021-02-0532,1760 total
    Common Stock (32,176 underlying)
  • Conversion

    2020B Convertible Promissory Note

    2021-02-05$17.00/sh735,475$12,503,0750 total
    Exp: 2022-12-11Common Stock (735,475 underlying)
Transactions
  • Conversion

    Common Stock

    2021-02-05+3,754,0843,754,084 total
  • Conversion

    Series B Convertible Preferred

    2021-02-053,754,0840 total
    Common Stock (3,754,084 underlying)
  • Conversion

    Common Stock

    2021-02-05$17.00/sh+735,475$12,503,075735,475 total
  • Conversion

    Common Stock

    2021-02-05+32,17632,176 total
  • Conversion

    Series B Convertible Preferred

    2021-02-0532,1760 total
    Common Stock (32,176 underlying)
  • Conversion

    Common Stock

    2021-02-05+5,173,0265,173,026 total
  • Purchase

    Common Stock

    2021-02-05$17.00/sh+3,461,764$58,849,9883,461,764 total
  • Conversion

    Series C Convertible Preferred

    2021-02-055,173,0260 total
    Common Stock (5,173,026 underlying)
  • Conversion

    2020B Convertible Promissory Note

    2021-02-05$17.00/sh735,475$12,503,0750 total
    Exp: 2022-12-11Common Stock (735,475 underlying)
Transactions
  • Conversion

    Common Stock

    2021-02-05+32,17632,176 total
  • Conversion

    Common Stock

    2021-02-05+3,754,0843,754,084 total
  • Conversion

    Common Stock

    2021-02-05$17.00/sh+735,475$12,503,075735,475 total
  • Conversion

    Series B Convertible Preferred

    2021-02-053,754,0840 total
    Common Stock (3,754,084 underlying)
  • Conversion

    Common Stock

    2021-02-05+5,173,0265,173,026 total
  • Conversion

    2020B Convertible Promissory Note

    2021-02-05$17.00/sh735,475$12,503,0750 total
    Exp: 2022-12-11Common Stock (735,475 underlying)
  • Conversion

    Series B Convertible Preferred

    2021-02-0532,1760 total
    Common Stock (32,176 underlying)
  • Purchase

    Common Stock

    2021-02-05$17.00/sh+3,461,764$58,849,9883,461,764 total
  • Conversion

    Series C Convertible Preferred

    2021-02-055,173,0260 total
    Common Stock (5,173,026 underlying)
Transactions
  • Conversion

    Series C Convertible Preferred

    2021-02-055,173,0260 total
    Common Stock (5,173,026 underlying)
  • Purchase

    Common Stock

    2021-02-05$17.00/sh+3,461,764$58,849,9883,461,764 total
  • Conversion

    Series B Convertible Preferred

    2021-02-053,754,0840 total
    Common Stock (3,754,084 underlying)
  • Conversion

    Common Stock

    2021-02-05+5,173,0265,173,026 total
  • Conversion

    Common Stock

    2021-02-05+3,754,0843,754,084 total
  • Conversion

    2020B Convertible Promissory Note

    2021-02-05$17.00/sh735,475$12,503,0750 total
    Exp: 2022-12-11Common Stock (735,475 underlying)
  • Conversion

    Common Stock

    2021-02-05+32,17632,176 total
  • Conversion

    Common Stock

    2021-02-05$17.00/sh+735,475$12,503,075735,475 total
  • Conversion

    Series B Convertible Preferred

    2021-02-0532,1760 total
    Common Stock (32,176 underlying)
Transactions
  • Conversion

    Common Stock

    2021-02-05+3,754,0843,754,084 total
  • Conversion

    Series B Convertible Preferred

    2021-02-053,754,0840 total
    Common Stock (3,754,084 underlying)
  • Conversion

    Series C Convertible Preferred

    2021-02-055,173,0260 total
    Common Stock (5,173,026 underlying)
  • Conversion

    Common Stock

    2021-02-05+32,17632,176 total
  • Conversion

    Common Stock

    2021-02-05+5,173,0265,173,026 total
  • Purchase

    Common Stock

    2021-02-05$17.00/sh+3,461,764$58,849,9883,461,764 total
  • Conversion

    Series B Convertible Preferred

    2021-02-0532,1760 total
    Common Stock (32,176 underlying)
  • Conversion

    2020B Convertible Promissory Note

    2021-02-05$17.00/sh735,475$12,503,0750 total
    Exp: 2022-12-11Common Stock (735,475 underlying)
  • Conversion

    Common Stock

    2021-02-05$17.00/sh+735,475$12,503,075735,475 total
Footnotes (9)
  • [F1]Each share of Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock") automatically converted on a one-for-one basis into Common Stock upon the closing of the Issuer's initial public offering (the "IPO"), for no additional consideration. The shares of Preferred Stock have no expiration date.
  • [F2]The convertible promissory note automatically converted into shares of the Issuer's Common Stock upon the closing of the IPO.
  • [F3]Chad Boeding is the beneficial owner of these shares through a trust that he controls.
  • [F4]EPQ LLC, LFLU PS ("LFLU") is the direct beneficial owner of these shares.
  • [F5]EPQ LLC, LCOVD PS ("LCOVD") is the direct beneficial owner of these shares.
  • [F6]EPQ LLC, LCOVD SAFE PS ("SAFE") is the direct beneficial owner of this shares.
  • [F7]EPQ LLC, LTEST PS ("LTEST") is the direct beneficial owner of these shares.
  • [F8]EPIQ Capital Group, LLC ("EPIQ") may be deemed an indirect beneficial owner of 13,124,349 shares of Issuer's Common Stock, which are held by LFLU (3,754,084 shares), LCOVD (5,173,026 shares), SAFE (735,475 shares), and LTEST (3,461,764 shares).
  • [F9]The reporting persons are EPIQ, Chad Boeding, LFLU, LCOVD, SAFE, and LTEST. EPIQ is the managing member of and LFLU, LCOVD, SAFE, and LTEST. Mr. Boeding is the CEO and Manager of EPIQ. EPIQ is filing this Form 4 on behalf of the reporting persons jointly, but not as a group. LFLU, LCOVD, SAFE, LTEST and Mr. Boeding each disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934 except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Issuer

Lucira Health, Inc.

CIK 0001652724

Entity typeother
IncorporatedCA

Related Parties

1
  • filerCIK 0001779453

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 6:39 PM ET
Size
30.5 KB